Lobe Sciences Ltd. (LOBE.CN)
Canadian Sec · CAD · Healthcare · Biotechnology
CA$0.055 (+37.50%) as of
Key statistics
- Market cap
- 16.95M
- EPS (TTM)
- -0.0400
- Dividend yield
- 0.00%
- 52-week range
- 0.0300 – 0.1800
- Beta
- 0.18
- Profit margin
- 0.00%
- Volume
- 82.00k
About Lobe Sciences Ltd.
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The company was founded in 2018 and is headquartered in Vancouver, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Vancouver, BC, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.